SCHEMBL19932307

SCHEMBL19932307

CNC(=O)C(CNC(C)C)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 2/20 0.47
CRHR2 Q13324 2/20 0.47
APAF1 O14727 1/20 0.46
LMNA P02545 2/20 0.45
ADRB2 P07550 2/20 0.44
ADRB1 P08588 2/20 0.44
ADRB3 P13945 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC6A3 Q01959 1/20 0.41
POLB P06746 1/20 0.41
KCNQ2 O43526 1/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP14 P50281 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23320094 0.81 ALDH1A1 (0.49) CRHBPCRHR2LMNAALDH1A1HTT
SCHEMBL13012350 0.81 EPHX1 (0.54) CRHBPCRHR2APAF1LMNAADRB2
SCHEMBL2721958 0.79 LMNA (0.50) CRHBPCRHR2LMNAALDH1A1HTT
SCHEMBL2049579 0.79 ALDH1A1 (0.66) CRHBPCRHR2LMNAALDH1A1HTT
SCHEMBL27418259 0.79 LMNA (0.44) CRHBPCRHR2LMNAALDH1A1HTT
Ethane SCHEMBL27961526 0.78 CTSK (0.55) CRHBPCRHR2LMNAALDH1A1HTT
SCHEMBL7504901 0.77 LMNA (0.49) CRHBPCRHR2LMNAALDH1A1HTT
SCHEMBL9055208 0.77 ROCK2 (0.50) CRHBPCRHR2LMNAALDH1A1HTT
SCHEMBL19256857 0.77 ROCK2 (0.50) CRHBPCRHR2LMNAALDH1A1HTT
SCHEMBL528413 0.76 CYP1A2 (0.56) CRHBPCRHR2LMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354643-B1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS INC (US) 2020-10-28 EP disclosed
EP-3354643-A1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2018-08-01 EP disclosed
EP-3053913-B1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS INC (US) 2018-03-07 EP disclosed